Cyclobenzaprine Hydrochloride
Product Images NDC 70934-063

2 FDA label images from Denton Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 70934-063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

70934 063 15 Master Bottle Label Approval Rev B 09 19

70934 063 15 Master Bottle Label Approval Rev B 09 19
Packaging label for Cyclobenzaprine Hydrochloride Tablets USP 10 mg by Denton Pharma, Inc. The label indicates a 15-tablet count with storage instructions between 20° and 25°C. It includes the NDC 70934-063-15, notes that the tablets are prescription-only, and cautions to keep out of reach of children. Additional details include lot numbers, expiration dates, and manufacturing information on accompanying peel panels.*
FDA Label Image

Structural Formula For Cyclobenzaprine. (Cyclobenzaprine 1)

Structural Formula For Cyclobenzaprine. (Cyclobenzaprine 1)
Chemical structure of Cyclobenzaprine Hydrochloride showing its polycyclic molecular framework with an attached hydrochloride group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.